Related Experiment Video
Updated: May 7, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
[Therapeutic management of non-valvular atrial fibrillation. Update 2013]
1Abteilung für Rhythmologie, Herzzentrum Leipzig, Universität Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland, kerstin.bode@med.uni-leipzig.de.
Insights
Atrial fibrillation affects 10% of elderly individuals in western countries. Management focuses on preventing blood clots and controlling heart rate or rhythm to improve patient well-being.
Area of Science:
- Cardiology
- Geriatrics
- Internal Medicine
Context:
- Atrial fibrillation (AF) is a common condition affecting 10% of individuals over 65 in western countries.
- Effective management of AF is crucial for preventing thromboembolic complications and cardiovascular comorbidities.
Purpose:
- To outline current therapeutic strategies for atrial fibrillation, focusing on anticoagulation and symptom management.
- To highlight the importance of individual risk assessment (e.g., CHA2DS2-Vasc score) in guiding AF treatment.
- To discuss rate and rhythm control strategies for alleviating AF-related symptoms.
Summary:
- Therapy for atrial fibrillation prioritizes thromboembolic prophylaxis via anticoagulation, tailored to patient risk scores like CHA2DS2-Vasc.
- Symptom management involves rate control (resting heart rate <110/min) or rhythm control (cardioversion, antiarrhythmic drugs, catheter ablation).
- The long-term prognostic benefit of maintaining sinus rhythm in AF patients remains under investigation in ongoing clinical trials.
Impact:
- Provides a concise overview of current atrial fibrillation management guidelines.
- Emphasizes the individualized approach to anticoagulation and symptom control in elderly patients.
- Informs clinicians and researchers about the ongoing evaluation of rhythm control strategies for improving AF patient outcomes.
Abstract:
In western countries one in ten of elderly persons (> 65 years old) will develop atrial fibrillation. The main goal in atrial fibrillation therapy is the prophylaxis of thromboembolic complications through anticoagulation according to the individual risk profile (CHA2DS2-Vasc score) of patients and treatment of cardiovascular comorbidities. Symptoms during atrial fibrillation guide the further therapeutic concept. Doctors can deploy a rate control strategy with a heart rate at rest less than 110/min and/or a rhythm control strategy with cardioversion, antiarrhythmic drugs and catheter ablation to alleviate complaints. To what extent maintaining the sinus rhythm improves the prognosis of atrial fibrillation patients is part of ongoing trials.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

